243 related articles for article (PubMed ID: 8752295)
1. Review of rotavirus vaccine trials in Finland.
Vesikari T; Joensuu J
J Infect Dis; 1996 Sep; 174 Suppl 1():S81-7. PubMed ID: 8752295
[TBL] [Abstract][Full Text] [Related]
2. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
[TBL] [Abstract][Full Text] [Related]
4. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
Rennels MB; Wasserman SS; Glass RI; Keane VA
Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of rhesus rotavirus vaccine MMU-18006 against gastroenteritis due to serotype 1 rotavirus.
Ukae S; Nakata S; Adachi N; Kogawa K; Chiba S
Vaccine; 1994 Aug; 12(10):933-9. PubMed ID: 7975835
[TBL] [Abstract][Full Text] [Related]
6. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children.
Vesikari T; Kapikian AZ; Delem A; Zissis G
J Infect Dis; 1986 May; 153(5):832-9. PubMed ID: 3009634
[TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group.
Ward RL; Bernstein DI
Vaccine; 1995 Sep; 13(13):1226-32. PubMed ID: 8578808
[TBL] [Abstract][Full Text] [Related]
8. Field trial of rhesus rotavirus vaccine in infants.
Christy C; Madore HP; Pichichero ME; Gala C; Pincus P; Vosefski D; Hoshino Y; Kapikian A; Dolin R
Pediatr Infect Dis J; 1988 Sep; 7(9):645-50. PubMed ID: 2845349
[TBL] [Abstract][Full Text] [Related]
9. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
Joensuu J; Koskenniemi E; Pang XL; Vesikari T
Lancet; 1997 Oct; 350(9086):1205-9. PubMed ID: 9652561
[TBL] [Abstract][Full Text] [Related]
10. Tetravalent human-rhesus reassortant rotavirus vaccine: a review of its immunogenicity, tolerability and protective efficacy against paediatric rotavirus gastroenteritis.
Foster RH; Wagstaff AJ
BioDrugs; 1998 Feb; 9(2):155-78. PubMed ID: 18020551
[TBL] [Abstract][Full Text] [Related]
11. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
Kapikian AZ; Flores J; Hoshino Y; Midthun K; Gorziglia M; Green KY; Chanock RM; Potash L; Sears SD; Clements ML
Rev Infect Dis; 1989; 11 Suppl 3():S539-46. PubMed ID: 2548276
[TBL] [Abstract][Full Text] [Related]
12. Trials of oral bovine and rhesus rotavirus vaccines in Finland: a historical account and present status.
Vesikari T
Arch Virol Suppl; 1996; 12():177-86. PubMed ID: 9015114
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group.
Rennels MB; Glass RI; Dennehy PH; Bernstein DI; Pichichero ME; Zito ET; Mack ME; Davidson BL; Kapikian AZ
Pediatrics; 1996 Jan; 97(1):7-13. PubMed ID: 8545227
[TBL] [Abstract][Full Text] [Related]
14. Rotavirus vaccine studies in Europe.
Vesikari T
Acta Paediatr Suppl; 1999 Jan; 88(426):9-13. PubMed ID: 10088905
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials of live oral rotavirus vaccines: the Finnish experience.
Vesikari T
Vaccine; 1993; 11(2):255-61. PubMed ID: 8382419
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity.
Vesikari T; Varis T; Green K; Flores J; Kapikian AZ
Vaccine; 1991 May; 9(5):334-9. PubMed ID: 1651610
[TBL] [Abstract][Full Text] [Related]
17. Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses.
Jin Q; Ward RL; Knowlton DR; Gabbay YB; Linhares AC; Rappaport R; Woods PA; Glass RI; Gentsch JR
Arch Virol; 1996; 141(11):2057-76. PubMed ID: 8973523
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine.
Takala AK; Koskenniemi E; Joensuu J; Mäkelä M; Vesikari T
Clin Infect Dis; 1998 Aug; 27(2):272-82. PubMed ID: 9709876
[TBL] [Abstract][Full Text] [Related]
19. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups.
Madore HP; Christy C; Pichichero M; Long C; Pincus P; Vosefsky D; Kapikian AZ; Dolin R
J Infect Dis; 1992 Aug; 166(2):235-43. PubMed ID: 1321858
[TBL] [Abstract][Full Text] [Related]
20. Reappraisal of the Peruvian and Brazilian lower titer tetravalent rhesus-human reassortant rotavirus vaccine efficacy trials: analysis by severity of diarrhea.
Linhares AC; Lanata CF; Hausdorff WP; Gabbay YB; Black RE
Pediatr Infect Dis J; 1999 Nov; 18(11):1001-6. PubMed ID: 10571438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
